Fig. 3From: Determining the prognosis of Lung cancer from mutated genes using a deep learning survival model: a large multi-center studyLeast absolute shrinkage and selection operator (LASSO) selection of genes and pathway analysis. (a, b) Optimal somatic mutations selected in patients with non-small cell lung cancer who did or did not receive immunotherapy. (c, d) Enrichment analysis of somatic mutations and different signaling pathwaysBack to article page